TERRA FLUXA
Longevity & Transhumanism
Longevity and transhumanist technologies enable extended healthspan and human capability when conventional medicine reaches its limits in addressing biological aging. We target cellular reprogramming, advanced therapeutics, and human augmentation systems.
The field is shifting from treating age-related disease to targeting aging as a root cause. Most traditional drug development remains too slow and narrowly focused to keep pace with rapid progress in biotechnology. We back early-stage founders building the foundational platforms and therapies that could meaningfully extend healthy human lifespan and enhance physical and cognitive performance.